MAT Act Signed Into Law, NABP Applauds Benefits for Overdose Prevention and Recovery Support
Shortly before the new year, President Joseph R. Biden signed the Consolidated Appropriations Act for 2023, which includes significant legislation to address the worsening overdose crisis. The National Association of Boards of Pharmacy® (NABP®) applauds the passage of the bill and its Mainstreaming Addiction Treatment Act (MAT Act) provision, which will remove federal barriers to […]
Read More ›NABP Joins Other Regulatory Associations In Launching Opioid Regulatory Collaborative
NABP and three other state board associations, have launched the Opioid Regulatory Collaborative (ORC). The ORC will bring together senior leaders from NABP, the American Association of Dental Boards, the Federation of State Medical Boards, and the National Council of State Boards of Nursing to share resources and strategies to slow opioid substance use disorder […]
Read More ›Medication Importation Requires More Study to Ensure Patient Safety, Cautions NABP
The National Association of Boards of Pharmacy® (NABP®) renewed its call to more carefully study the safety implications of allowing importation of prescription drugs from Canada after the Trump Administration announced plans to allow this activity. In a letter to its members, the state boards of pharmacy, NABP cautioned that allowing such practices places American patients at risk. […]
Read More ›White House Targets Drug Pricing, Importation Through Executive Action
Written by: Matthew Rubin and Libby Baney, Faegre Drinker Consulting The Trump Administration reignited its focus on prescription drug affordability and access last month through a series of executive orders targeting several longstanding priorities intended to drive costs down. On July 24, 2020, President Donald J. Trump signed four executive orders focused on cost, and […]
Read More ›NABP Urges Congressional Leaders to Continue Supporting Federal Programs to Combat Both Opioid Epidemic and COVID-19
Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]
Read More ›U.S. Healthcare Licensing and Regulatory Organizations Issue Joint Statement on COVID-19 Pandemic
As the leading national organizations representing state and territorial health regulatory boards in the United States that regulate the practice of medicine, nursing, pharmacy, physical therapy, psychology, occupational therapy, and social work, we wish to express support for the many efforts being undertaken by our member boards and staff to enable health care providers and […]
Read More ›White and Brown Bagging Emerging Practices, Emerging Regulation
At the NABP 112th Annual Meeting in May 2016, the membership passed Resolution 112‐1‐16 requesting that NABP conduct a study to review and define the practices of “white bagging” and “brown bagging,” and recommend regulatory language, if necessary, to The Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy […]
Read More ›So-Called “Canadian” Pharmacies are a Danger to Consumers, NABP Reports
The National Association of Boards of Pharmacy® (NABP®) released the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: August 2017. The report discusses how rogue online pharmacies exploit the American perception that Canadian pharmacies provide safe medication at a lower cost. In a recent study, NABP reviewed more than 100 pharmacy […]
Read More ›Task Force of Physicians Encourages Use of PMPs to Help Protect Patients From Prescription Drug Abuse
In response to the prescription opioid abuse epidemic, a task force of physician groups is urging physicians to register for and use prescription monitoring programs (PMPs) as part of the decision-making process when considering treatment options. The American Medical Association (AMA) Task Force to Reduce Opioid Abuse will focus on identifying best practices to combat prescription […]
Read More ›Illegal Online Sellers Most Frequent Distributors of Counterfeit Drugs, Reports NABP
.Pharmacy gTLD and Consumer Education Key in Protecting Public Health The National Association of Boards of Pharmacy® (NABP®) today issued a report stressing that illegal online drug sellers are the most frequent conduits of counterfeit drugs and pose a continued threat to global public health. As detailed in the Internet Drug Outlet Identification Program Progress […]
Read More ›